Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Johnson & Johnson
Ownership Structure: publicly traded (ticker symbol JNJ)
Headquartered in: New Jersey
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Subsidy Summary | Subsidy Value | Number of Awards |
State/Local | $111,279,431 | 124 |
Federal (grants and allocated tax credits) | $0 | 0 |
TOTAL | $111,279,431 | 124 |
Loan / Bailout Summary | Total Face Value | Number of Awards |
State/Local loans, bond financing and venture capital | $0 | 0 |
Federal loans, loan guarantees and bailout assistance (not including repayments) | $10,800,000 | 3 |
TOTAL | $10,800,000 | 3 |
Time Period for State and Local Awards: Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2011.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
For an overview of this company's accountability track record, read its Corporate Rap Sheet
here.
Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
Pennsylvania | $52,478,642 | 29 |
New York | $25,476,429 | 20 |
Florida | $16,575,000 | 5 |
Massachusetts | $8,246,427 | 14 |
Kentucky | $3,960,000 | 1 |
All other | $4,542,933 | 55 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
SYNTHES U.S.A., LLC | New York | state | 2010 | $1,980,000 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2001 | $620,000 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2002 | $828,938 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2011 | $2,366,358 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2012 | $1,457,431 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2013 | $2,311,702 | | enterprise zone |
SYNTHES U.S.A., LLC | New York | state | 2014 | $1,028,677 | | enterprise zone |
ETHICON ENDO-SURGERY INC | New Mexico | state | 2012 | $281,091 | | tax credit/rebate |
CENTOCOR BIOLOGICS, LLC SERIES 2005 | Missouri | state | 2006 | $386,661 | | tax credit/rebate |
Codman and Shurtleff, Inc. | Massachusetts | state | 2011 | $66,093 | | tax credit/rebate |
Depuy Mitek, Inc. | Massachusetts | state | 2011 | $20,717 | | tax credit/rebate |
Depuy Spine, Inc. | Massachusetts | state | 2011 | $85,255 | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
DePuy Othopaedics, Inc. | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Momenta Pharmaceuticals, Inc | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Depuy Mitek, Inc. | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Depuy Spine, Inc. | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Codman and Shurtleff, Inc. | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Massachusetts | state | 2013 | $1,715,000 | | tax credit/rebate |
Depuy Mitek, Inc. | Massachusetts | state | 2013 | $68,023 | | tax credit/rebate |
Codman & Shurtleff, Inc. | Massachusetts | state | 2013 | $115,391 | | tax credit/rebate |
Depuy Spine, Inc. | Massachusetts | state | 2013 | $43,223 | | tax credit/rebate |
Abiomed Inc | Massachusetts | state | 2017 | $750,000 | | tax credit/rebate |
Abiomed, Inc. | Massachusetts | state | 2016 | $1,050,000 | | tax credit/rebate |
Abiomed, Inc. | Massachusetts | state | 2018 | $750,000 | | tax credit/rebate |
Abiomed, Inc | Massachusetts | state | 2019 | $459,125 | | tax credit/rebate |
Abiomed Inc. | Massachusetts | state | 2021 | $675,000 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT LLC (AKA JRD LLC) | Maryland | state | 2020 | $16,769 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT | Maryland | state | 2021 | $29,953 | | tax credit/rebate |
Janssen Research & Development | Maryland | state | 2022 | $19,167 | | tax credit/rebate |
JOM Pharmaceutical Services, Inc. | Kentucky | state | 2007 | $3,960,000 | | tax credit/rebate |
Johnson & Johnson Health Care Systems Inc. | Indiana | state | 2020 | $2,250,000 | | tax credit/rebate |
Johnson & Johnson Health Care Systems Inc. | Indiana | state | 2010 | $300,000 | | tax credit/rebate |
McNeil Consumer Healthcare Division of McNEll-PPC, | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
Johnson and Johnson Vision Care, Inc. | Florida | state | 2014 | $1,300,000 | | grant |
Johnson & Johnson Vision Care, Inc. | Florida | local | 2016 | $7,100,000 | | grant |
Johnson & Johnson Vision Care, Inc. | Florida | state | 2016 | $1,000,000 | | grant |
Johnson & Johnson Consumer Inc. | Florida | state | 2018 | $175,000 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Florida | state | 2013 | undisclosed | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Florida | state | 2015 | undisclosed | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Florida | local | 2021 | $7,000,000 | | grant |
BIOSENSE WEBSTER, INC. | California | state | 2003 | $78,520 | | training reimbursement |
NEUTROGENA CORPORATION | California | state | 2003 | $202,588 | | training reimbursement |